| BIOVAXYS TECHNOLOGY CORP. |
| Kanada |
| Gesundheit |
| CA09076M2004 / A41C58 |
| 5LB0 (Frankfurt) |
| FRA:5LB0, ETR:5LB0, 5LB0:GR |
| - |
| https://www.biovaxys.com/ |
|
BioVaxys Technology Corp. is a clinical-stage biot..
>Volltext.. |
| 4.7 Mio. EUR |
| 4.78 Mio. EUR |
| - |
| -3.05 Mio. EUR |
| -3.76 Mio. EUR |
| -0.14 EUR |
| 0.08 Mio. EUR |
| - |
| -1.85 Mio. EUR |
| - |
| - |
| -17.07% |
| - |
| - |
| - |
| - |
| BIOVAXYS |
| 19.01.26 |
|